MASSDEVICE ON CALL — Technology titan Google (NSDQ:GOOG) is taking new interest in human health in the latest "moonshot" project coming out of its ambitious "X" lab, famous for self-driving cars and Google Glass.
The new Baseline Study will collect and analyze genomic and molecular data, starting with 175 volunteers and expanding eventually to thousands of participants, to built a rich database of human health.
First reported by the Wall Street Journal, the project is the latest Google initiative that breaches the narrowing divide between technology and medicine, joining the company’s Calico life-extension project and the newer "smart" contact lenses for measuring blood glucose and other biomarkers.
According to the Journal:
Other mass medical and genomics studies exist. But Baseline will amass a much larger and broader set of new data. The hope is that this will help researchers detect killers such as heart disease and cancer far earlier, pushing medicine more toward prevention rather than the treatment of illness.
Medtronic lands patent for vagal stimulation
More than 2 years following original submission, Medtronic (NYSE:MDT) lands approval for a patent described as "methods for treating heart conditions using vagal stimulation, and further to devices for performing such treatment."
Intuitive Surgical sponsors physician training program
Beleaguered Intuitive Surgical (NSDQ:ISRG) touts the company-backed launch of the 1st annual Intuitive Surgical Robotics Fellowship Course through the American Assn. for Thoracic Surgery.
Ireland bites back against Capitol Hill anti-inversion rhetoric
Irish regulators fired back after the White House accused the country’s officials of luring U.S. companies away with lofty promises.
In-depth in the FDA’s regulation of mobile medical apps
The FDA recently released its guidelines for mobile medical apps, an area rich with entrepreneurs facing the FDA for the 1st time.